Restoring SCN1A-Mediated Neuronal Excitability Through Cell-Selective Gene Regulation in Clinical Dravet Syndrome

  • Demonstrating durable SCN1A upregulation using AAV9-based gene regulation in clinical development
  • Translating cell-selective targeting of inhibitory neurons into disease-modifying potential in Dravet syndrome
  • Optimizing precision gene control strategies to improve safety and efficacy in CNS ion channel disorders